By Rentschler Biopharma…
To get in touch with Rentschler Biopharma SE, simply fill out the form below.
Subscribe to Supplier
Rentschler presenting biopharmaceutical development and manufacturing solutions at BIO International
Laupheim, Germany: Full-service biopharmaceutical Contract Development and Manufacturing Organization (CDMO) Rentschler Biotechnologie GmbH will bring its expertise in mammalian cell culture and related biopharmaceutical solutions to the landmark BIO International Convention in San Diego later this month.
This is a return to BIO International for Rentschler, which will exhibit at Booth 1929 in Hall C at the San Diego Convention Center, along with strategic partners Leukocare AG and Rentschler Fill Solutions.
“BIO International provides a great platform to represent Rentschler’s solutions for bioprocess development and manufacturing of biopharmaceuticals,” said Rentschler Biotechnologie Senior Director Company Communications, Dr. Marion Schrader. “It is also a great forum in which to present the recently announced strategic Alliance with Leukocare AG as well as the strategic Partnership with Rentschler Fill Solutions GmbH.” said Dr. Schrader.
Creating competitive advantages for clients with best-in-class formulations
The Alliance between Rentschler Biotechnologie GmbH and Leukocare AG strategically aims to incorporate formulation development at every step throughout biopharmaceutical development and manufacturing. Leukocare is the specialized technology partner and exclusive formulation developer for Rentschler’s biopharmaceutical business. Working closely with the client, this will ensure that the end products will – from the very beginning – have a best-in-class formulation and administration mode. This innovative approach will provide clients significant competitive advantages, enabling them to exploit the full potential of their products and markets.
One-stop solutions with new state-of-the-art fill and finish facilities
The strategic partnership of Rentschler Biotechnologie GmbH and Rentschler Fill Solutions GmbH provides clients with one-stop solutions for biopharmaceutical products and unites two centers of excellence for the fast and efficient bioprocess development, manufacturing and filling of biopharmaceuticals with the Rentschler commitment to quality. Both companies are owned by the Rentschler family, which has been a trusted and successful partner in the pharmaceutical industry for five generations. While the Companies remain independent of one another, Rentschler Fill Solutions will serve as exclusive partner for the fill and finish of Rentschler Biotechnologie’s full-service manufacturing projects
About Rentschler Biotechnologie
Rentschler Biotechnologie GmbH, located in Laupheim, Germany, is a leading contract development and manufacturing organization (CDMO) for bioprocess development and manufacturing of biopharmaceuticals as well as for related consulting activities in terms of project management and regulatory support.
The Company’s clients include innovative biotech companies and major pharmaceutical companies around the world. Many years of experience and excellence in finding solutions as well as certified quality management and advanced technologies ensure Rentschler’s high quality standards.
Rentschler Biotechnologie is a family-owned company employing approximately 700 people.
About BIO International
The BIO International Convention (BIO) provides a week of intensive networking for biotechnology and pharma leaders to discover new opportunities and promising partnerships. It attracts more than 16,000 delegates involved in a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.
BIO International 2017 is a four-day event opening June 19 at the harbor-side San Diego Convention Center in southern California. The convention will feature more than 35,000 face-to-face meetings for some 3,100 companies organized using the proprietary BIO One-on-One partnering™ system, as well as hundreds of individual company presentations, a program of world-renowned keynote speakers and some 20 session tracks.
A co-located trade show will feature more than 1,800 exhibitors from fields ranging from digital health and diagnostics to bioprocesses.
You will find more information at: http://convention.bio.org/